{"paper_id":"448cbd91-a999-4130-9128-7fdbc766f3f4","body_text":"Main Article Content\nThe use of Goserelin in the management of endometriosis\nAbstract\nequivalent to 3.6mg Goserelin)\nJournal / Obstetrics and Gynaecology Forum / Vol. 19 No. 1 (2009) / Articles\nZoladex (Goserelin acetate implant) contains a synthetic decapeptide analogue of luteinising hormone releasing (GnRH) agonist analogue. Zoladex is designed for subcutaneous injection (sterile biodegradable product\nequivalent to 3.6mg Goserelin)\nequivalent to 3.6mg Goserelin)\neISSN: 1027-9148\nprint ISSN: 1029-1962","source_license":"CC0","license_restricted":false}